The Latest Cardiac and Vascular News
SILVER SPRING, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today product design completion for CanGaroo® with antibiotics, the next generation of the Company’s CanGaroo […]
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has entered into securities purchase agreements with several institutional investors to purchase an […]
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), is researching the potential development of a radio based computer vision system to be guided by AI for cardiovascular applications. This is the first phase of the research to evaluate an autonomous arterial […]
Investment Will Be Used to Scale Product Platform, Expand Nationally, Internationally and Grow Team FREMONT, Calif., Feb. 11, 2021 /PRNewswire/ — Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today it has raised $22 Million in Series C funding. The round included […]
FREMONT, Calif. and OXFORD, United Kingdom, Feb. 11, 2021 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Contour Neurovascular System™. Breakthrough Device Designation is granted to medical devices and device-led combination products […]
Virtual Presence Solution Provides OR Access to Proctor Required to Oversee Critical Aneurysm Implant Procedure in New Device Trial CENTER VALLEY, Pa., Feb. 11, 2021 /PRNewswire/ — Olympus announced today its cloud-based virtual medical presence platform known as MedPresence® was critical in allowing the first use in the U.S. of a novel intracranial vascular […]
The Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose study design assessed the safety and pharmacodynamics with dapansutrile in subjects with stable heart failure with reduced ejection fraction (HFrEF) Antonio Abbate MD PhD, the Principal Investigator, is Professor of Medicine and Medical Director of the Clinical Research Unit at […]
TARRYTOWN, N.Y., Feb. 11, 2021 /PRNewswire/ — Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that affects approximately 1,300 patients in the U.S. and is characterized by extremely high low-density lipoprotein cholesterol (LDL-C) In pivotal Phase 3 HoFH trial, adding Evkeeza to standard lipid-lowering therapies reduced LDL-C by nearly half at 24 […]
The technology used in the Rapid® platform is highly unique and scalable and can deliver exceptional cost efficiencies to hospitals of all sizes SANTA CLARA, Calif., Feb. 10, 2021 /PRNewswire/ — Based on its recent analysis of the global intelligent imaging analysis systems market, Frost & Sullivan recognizes RapidAI with the 2020 Global Growth, Innovation & […]
Investigational device has the potential to transform a half-century-old standard of care BOSTON, Feb. 10, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, has treated the first patient in a study of its eShunt System, an investigational device intended to treat communicating […]
